Your browser doesn't support javascript.
loading
Multi-ancestry study of the genetics of problematic alcohol use in >1 million individuals.
Zhou, Hang; Kember, Rachel L; Deak, Joseph D; Xu, Heng; Toikumo, Sylvanus; Yuan, Kai; Lind, Penelope A; Farajzadeh, Leila; Wang, Lu; Hatoum, Alexander S; Johnson, Jessica; Lee, Hyunjoon; Mallard, Travis T; Xu, Jiayi; Johnston, Keira J A; Johnson, Emma C; Galimberti, Marco; Dao, Cecilia; Levey, Daniel F; Overstreet, Cassie; Byrne, Enda M; Gillespie, Nathan A; Gordon, Scott; Hickie, Ian B; Whitfield, John B; Xu, Ke; Zhao, Hongyu; Huckins, Laura M; Davis, Lea K; Sanchez-Roige, Sandra; Madden, Pamela A F; Heath, Andrew C; Medland, Sarah E; Martin, Nicholas G; Ge, Tian; Smoller, Jordan W; Hougaard, David M; Børglum, Anders D; Demontis, Ditte; Krystal, John H; Gaziano, J Michael; Edenberg, Howard J; Agrawal, Arpana; Justice, Amy C; Stein, Murray B; Kranzler, Henry R; Gelernter, Joel.
Afiliação
  • Zhou H; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Kember RL; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Deak JD; These authors contributed equally.
  • Xu H; Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.
  • Toikumo S; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Yuan K; These authors contributed equally.
  • Lind PA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Farajzadeh L; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Wang L; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Hatoum AS; Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.
  • Johnson J; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Lee H; Stanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Mallard TT; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Xu J; Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Johnston KJA; School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
  • Johnson EC; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
  • Galimberti M; Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark.
  • Dao C; The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Denmark.
  • Levey DF; Center for Genomics and Personalized Medicine, Aarhus, Denmark.
  • Overstreet C; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Byrne EM; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Gillespie NA; Department of Psychological and Brain Sciences, Washington University in St. Louis, Saint Louis, MO, USA.
  • Gordon S; Pamela Sklar Division of Psychiatric Genomics, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Hickie IB; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Whitfield JB; Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Xu K; Stanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Zhao H; Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Huckins LM; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Davis LK; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Sanchez-Roige S; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Madden PAF; Department of Psychiatry, Washington University School of Medicine, Saint Louis, MO, USA.
  • Heath AC; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Medland SE; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Martin NG; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Ge T; Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, CT, USA.
  • Smoller JW; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Hougaard DM; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Børglum AD; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Demontis D; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Krystal JH; Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia.
  • Gaziano JM; Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
  • Edenberg HJ; Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Agrawal A; Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.
  • Justice AC; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Stein MB; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Kranzler HR; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
  • Gelernter J; Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
medRxiv ; 2023 Jan 30.
Article em En | MEDLINE | ID: mdl-36747741
Problematic alcohol use (PAU) is a leading cause of death and disability worldwide. To improve our understanding of the genetics of PAU, we conducted a large cross-ancestry meta-analysis of PAU in 1,079,947 individuals. We observed a high degree of cross-ancestral similarity in the genetic architecture of PAU and identified 110 independent risk variants in within- and cross-ancestry analyses. Cross-ancestry fine-mapping improved the identification of likely causal variants. Prioritizing genes through gene expression and/or chromatin interaction in brain tissues identified multiple genes associated with PAU. We identified existing medications for potential pharmacological studies by drug repurposing analysis. Cross-ancestry polygenic risk scores (PRS) showed better performance in independent sample than single-ancestry PRS. Genetic correlations between PAU and other traits were observed in multiple ancestries, with other substance use traits having the highest correlations. The analysis of diverse ancestries contributed significantly to the findings, and fills an important gap in the literature.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos